The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era is a research paper published in Biology of Blood and Marrow Transplantation (2020). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: U01 AI126612
NHLBI NIH HHS
Grant: U01 HL128568
NHLBI NIH HHS
Grant: U24 HL138660
NCI NIH HHS
Grant: P01 CA111412
NCI NIH HHS
Grant: R01 CA152108
NCI NIH HHS
Grant: R01 CA231141
NCI NIH HHS
Grant: U24 CA076518
NHLBI NIH HHS
Grant: R21 HL140314
NHLBI NIH HHS
Grant: R01 HL129472
NHLBI NIH HHS
Grant: R01 HL126589
NHLBI NIH HHS
Grant: R01 HL131731
FWCI
1.60
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals